Our company is a research service provider dedicated to developing new therapies to address the unique challenges posed by rare blood disorders. Our expert team works tirelessly to support our customers' research endeavors, offering cutting-edge solutions for enhanced diagnosis, therapeutics, and understanding of these complex conditions.
To facilitate timely and accurate diagnosis of rare blood disorders, we provide biomarker and diagnostic kit development services.
Read MoreWe develop multiple types of therapeutics such as small molecules, antibodies, peptides, proteins, cell therapies and gene therapies.
Read MoreWe construct reliable in vitro and animal disease models to support the study of disease pathology and drug efficacy.
Read MoreThrough safety, efficacy, and pharmacokinetic studies, our goal is to validate and optimize the potential of novel drug candidates.
Read More
Myeloproliferative Disorders (MPDs)
Bone Marrow Failure Syndromes (BMFS)
